Status Topic selection
Technology type Medicine
Decision Not selected
Reason for decision Not eligible for Health Technology Evaluation guidance
Further information Following information received from the company that the extension to their marketing authorisation for semaglutide will not add a significant new therapeutic indication. This technology does not meet the eligibility criteria for selection for technology appraisal and will subsequently be removed from the work programme.
ID number 11788

Project Team

Project lead Abigail Stephens

Email enquiries


Key events during the development of the guidance:

Date Update
06 March 2023 Topic selection. Changed as now not selected
09 January 2023 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on how we select topics for development, please see our page about topic selection